systemic chondromalacia - meaning and definition. What is systemic chondromalacia
Diclib.com
ChatGPT AI Dictionary
Enter a word or phrase in any language 👆
Language:

Translation and analysis of words by ChatGPT artificial intelligence

On this page you can get a detailed analysis of a word or phrase, produced by the best artificial intelligence technology to date:

  • how the word is used
  • frequency of use
  • it is used more often in oral or written speech
  • word translation options
  • usage examples (several phrases with translation)
  • etymology

What (who) is systemic chondromalacia - definition

HUMAN DISEASE
Meyenburg-Altherr-Uehlinger syndrome; Polychondritis; Polychondritis, relapsing; Atrophic polychondritis; Systemic chondromalacia; Meyenburg–Altherr–Uehlinger syndrome
  • A cauliflower ear deformity
  • Rudolf Jaksch von Wartenhorst]].

Systemic disease         
SYSTEMIC DISEASE IS ONE THAT AFFECTS A NUMBER OF ORGANS AND TISSUES, OR AFFECTS THE BODY AS A WHOLE
Systemic infection; Multisystem disease; Systemic illness; Systemic disorder; Systemic condition; Life-threatening disease; Systemic reaction
A systemic disease is one that affects a number of organs and tissues, or affects the body as a whole.Dorland's Illustrated Medical Dictionary,28th edition (Harcourt Brace & Company).
Systemic scleroderma         
  • Fibroblasts
SCLERODERMA THAT IS CHARACTERIZED BY FIBROSIS (OR HARDENING) OF THE SKIN AND MAJOR ORGANS, AS WELL AS VASCULAR ALTERATIONS, AND AUTOANTIBODIES
Systemic sclerosis; Systemic Sclerosis in Greece; SSc; Progressive systemic sclerosis; Systemic sclerosis (scleroderma); Diffuse cutaneous type systemic sclerosis; Diffuse cutaneous systemic sclerosis
Systemic scleroderma, or systemic sclerosis, is an autoimmune rheumatic disease characterised by excessive production and accumulation of collagen, called fibrosis, in the skin and internal organs and by injuries to small arteries. There are two major subgroups of systemic sclerosis based on the extent of skin involvement: limited and diffuse.
Sle         
  • epidermal]] cells (antinuclear antibodies are present).
  • Clearance deficiency
  • Germinal centres in a person with SLE and controls (schematic). Red: CD68 in tingible body macrophages; black: TUNEL positive apoptotic cells. 1) Healthy donors with florid germinal centres show giant tingible body macrophages (TBM) containing ingested apoptotic cells and no uningested apoptotic cells outside the TBM. 2) People with follicular lymphoma show small tingible body macrophages (TBM) containing few ingested apoptotic cells however, there are no uningested apoptotic cells outside the TBM. 3) Some with SLE (1) show a lack of TBM and many uningested apoptotic cells decorating the surfaces of spindle-shaped cells, presumably follicular dendritic cells (SLE 1). 4) Some people with SLE show TBM containing few ingested apoptotic cells and many uningested apoptotic cells outside the TBM (SLE 2). However, about 50 % of people with SLE show rather normal germinal centre.
  • date=2009-12-20 }} Last Editorial Review: 2009-01-30</ref>
INFLAMMATION OF CONNECTIVE TISSUE MARKED BY SKIN RASHES, JOINT PAIN AND SWELLING, INFLAMMATION OF THE KIDNEYS AND INFLAMMATION OF THE TISSUE SURROUNDING THE HEART.
Systemic Lupus Erythematosus; Lupus erythematodes; Systemic lupus erythamatosus; Lupus erythematosus, systemic; Lupus erythematosus, discoid; Lupus erythematosus, cutaneous; Systemic lupus erythematosis; Lupus disease; Osler-Libman-Sacks syndrome; Childhood systemic lupus erythematosus; Erythematosus; Lupus (S LE); Systemic lupus erythmatosis; Systemic lupus; Lupus erythematous; Lupus and the brain; Lupus treatment; Systemic lupus erythematosus; Angiolupoid; Lupoid syndrome; Systemic Lupus Erythematosus (SLE); Systemic lupus erythematosus (SLE); Systemic lupus erythemaosus; SLE; Osler–Libman–Sacks syndrome; Disseminated lupus erythematosus
·vt To Slay.

Wikipedia

Relapsing polychondritis

Relapsing polychondritis is a multi-systemic condition characterized by repeated episodes of inflammation and deterioration of cartilage. The often painful disease can cause joint deformity and be life-threatening if the respiratory tract, heart valves, or blood vessels are affected. The exact mechanism is poorly understood, but it is thought to be related to an immune-mediated attack on particular proteins that are abundant in cartilage.

The diagnosis is reached on the basis of the symptoms and supported by investigations such as blood tests and sometimes other investigations. Treatment may involve symptomatic treatment with painkillers or anti-inflammatory medications, and more severe cases may require suppression of the immune system.